Shuai Wang
14 Papers
Shuai Wang is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 7 publications.
Chat about Author
Papers
The schizophrenia and gut microbiota: A bibliometric and visual analysis
TL;DR: In this paper , Dinan et al. conducted a bibliometric study of this association to determine the current status and areas for advancement in this field and found that the studies about the association between gut microbiota and schizophrenia are limited, and more studies are needed to provide new insights into the gut microbiota in the pathogenesis and treatment of schizophrenia.
19
Exposure to perchlorate, nitrate and thiocyanate was associated with the prevalence of cardiovascular diseases.
Long Wang,Zhi Fu,Jingcheng Zheng,Shuai Wang,Yan Ping,Bei-Bei Gao,Xuming Mo,Ping Liang,Jinyu Huang +8 more
TL;DR: In this article , the association between urinary levels of perchlorate, nitrate and thiocyanate, and the prevalence of cardiovascular diseases (CVD) among general population was determined.
16
The prevalence of coronary microvascular dysfunction (CMD) in heart failure with preserved ejection fraction (HFpEF): a systematic review and meta-analysis.
Xiaoxiao Lin,Guomin Wu,Shuai Wang,Jinyu Huang +3 more
TL;DR: It is demonstrated that CMD is common in patients with HFpEF and might be associated with poor clinical outcomes in these patients, and Clinicians should attach importance to CMD in the diagnosis and treatment ofHFpEF.
10
Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
Xiaoxiao Lin,Guomin Wu,Shuai Wang,Jinyu Huang +3 more
TL;DR: The main research hotspots and frontiers in the field of doxorubicin-induced cardiotoxicity include the role ofDoxorUBicin in cardiot toxicity, the mechanisms underlying doxOrubicIn-inducedCardiotoxicity, and the development of treatment strategies for dox orubic in-induced Cardiotoxicity.
9
A Bibliometric Analysis of Alternate-Day Fasting from 2000 to 2023.
TL;DR: The main research hotspots and frontiers are ADF for obesity and cardiometabolic risk, andADF for several different population groups including healthy adults and patients with diabetes, nonalcoholic fatty liver disease (NAFLD), and cancer.
6